Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Presti

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Immunity|August 31, 2021
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Nature Medicine|March 5, 2021
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesRita E Chen, Xianwen Zhang, James Brett Case, et al.
Frontiers in Immunology|January 9, 2023
SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patientsFrank J Lin, Alexa Michelle Altman Doss, Hannah G Davis-Adams, et al.
Epidemics|January 17, 2026
Estimating influenza transmission parameters: Comparing two study designs, 2023-2024Jessica E Biddle, Stacey House, Jennie H Kwon, et al.
Biorxiv : the Preprint Server for Biology|September 29, 2022
SARS-CoV-2 Omicron boosting induces de novo B cell response in humansWafaa B Alsoussi, Sameer K Malladi, Julian Q Zhou, et al.
Nature|April 3, 2023
SARS-CoV-2 Omicron boosting induces de novo B cell response in humansWafaa B Alsoussi, Sameer Kumar Malladi, Julian Q Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical TrialNadine G Rouphael, Angela R Branche, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical TrialAngela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical TrialAngela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
Annals of Internal Medicine|August 30, 2021
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort StudyParakkal Deepak, Wooseob Kim, Michael A Paley, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Immunity|August 31, 2021
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Nature Medicine|March 5, 2021
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesRita E Chen, Xianwen Zhang, James Brett Case, et al.
Frontiers in Immunology|January 9, 2023
SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patientsFrank J Lin, Alexa Michelle Altman Doss, Hannah G Davis-Adams, et al.
Epidemics|January 17, 2026
Estimating influenza transmission parameters: Comparing two study designs, 2023-2024Jessica E Biddle, Stacey House, Jennie H Kwon, et al.
Biorxiv : the Preprint Server for Biology|September 29, 2022
SARS-CoV-2 Omicron boosting induces de novo B cell response in humansWafaa B Alsoussi, Sameer K Malladi, Julian Q Zhou, et al.
Nature|April 3, 2023
SARS-CoV-2 Omicron boosting induces de novo B cell response in humansWafaa B Alsoussi, Sameer Kumar Malladi, Julian Q Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical TrialNadine G Rouphael, Angela R Branche, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical TrialAngela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical TrialAngela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
Annals of Internal Medicine|August 30, 2021
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort StudyParakkal Deepak, Wooseob Kim, Michael A Paley, et al.
Pageof 10